Abstract
Oscillating biomarker response-time courses challenge modelling of drug intervention. A periodically recurring pattern is typically seen for the stress hormone cortisol. This pattern can be captured by mechanism-based turnover models. Bayesian hierarchical modelling allows for full quantification of parameter uncertainty while also capturing the population aspects typical to nonlinear mixed effects modelling. Inter-occasion variability (IOV) is incorporated in addition to inter-individual variability (IIV). Finally, the adjusted model is used to predict specificity of a clinical test.